Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Drugmaker, security experts urge removing requirement to publish pharmaceutical representatives’ names on state website
Summary
Pfizer and security witnesses urged the General Law Committee to remove a requirement to post pharmaceutical representatives' names on the Department of Consumer Protection website, arguing the disclosure increases safety risks for field employees.
Company and security representatives told the General Law Committee that an existing statute requiring publication of pharmaceutical representatives' names on the Department of Consumer Protection website raises safety concerns for front-line employees.
Pfizer security official Angel Melendez, who said he has decades of law-enforcement and national-security experience, told the committee that public posting of individual sales representatives' names creates a tangible safety risk…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
